The European Medicines Agency revised its policy on conflicts of interest in response to concerns regarding its ability to conduct independent evaluations.
Daily News Roundup
The European Medicines Agency revised its policy on conflicts of interest in response to concerns regarding its ability to conduct independent evaluations.
The FDA may require weight-loss drugs to undergo clinical trials to see if they pose a risk of heart attack.
The Obama administration pledges $200 million for better ways of managing and extracting information from large data sets.
The NIH plans an extra layer of review for scientists with at least $1.5 million in existing grants.
The US Supreme Court ordered patents held by Myriad Genetics to be reviewed further by the Federal Circuit Court.
Graduate students ask for more federal research support.
Through a confluence of events, academic medical centers could lose 10 percent of their revenue in the coming years.
Are donors of biological material privy to research results that stem from their donation?
GlaxoSmithKline and Johnson & Johnson contribute a total of $100 million to early-stage biotech endeavors.
A second advisor for the National Children’s Study resigns in response to changes in study design.